Liquidia Technologies is trading 4.1% down at $72.23, with the decline appearing tied mainly to a broader biotech pullback after the sector’s recent rally, alongside weaker major indexes and rising Treasury yields.
- No fresh company-specific announcement was identified for August 20, 2026.
- Recent second-quarter results may add pressure.
- An officer’s reported $5.97 million stock sale may also weigh, but neither directly explains today’s move.